Our findings suggest that ischemic stroke with sepsis patients, the potential benefits of early albumin combination therapy—possibly including superior volume expansion, endothelial stabilization, and neuroprotection—may be counterbalanced by its associated risks of pulmonary edema and cerebral hemorrhage. Here, ALB is linked to Sepsis.